Cantor Fitzgerald is maintaining a bearish stance on equities, cautioning that the recent market rebound which has been driven largely by investor positioning—is likely behind us. The firm ...

Cantor Fitzgerald is going all in on Bitcoin (BTC-USD ... holding roughly $55 billion and planning to raise another $84 billion through equity and debt to buy more. Michael Saylor isn't worried though ...

Fintel reports that on May 7, 2025, Cantor Fitzgerald downgraded their outlook for Marvell Technology (BMV:MRVL1) from Overweight to Neutral. There are 1,188 funds or institutions reporting ...

On Tuesday, Cantor Fitzgerald analyst Sarah James reaffirmed an Overweight rating on CVS Health (NYSE:CVS) with a steady price target of $71.00. The rating aligns with the company’s strong ...

Fintel reports that on May 5, 2025, Cantor Fitzgerald downgraded their outlook for Onto Innovation (BMV:ONTO) from Overweight to Neutral. There are 501 funds or institutions reporting positions in ...

According to Cantor, this delay suggests “potential catalysts will be few and far between over the near- to medium-term.” Related articles Gilead Sciences to invest $11 billion in U.S. R&D and ...

On Monday, Cantor Fitzgerald analysts revised their stance on Onto Innovation Inc. (NYSE:ONTO), downgrading the stock from Overweight to Neutral and significantly reducing the price target to $135 ...

On Monday, Cantor Fitzgerald analysts revised their stance on Onto Innovation Inc. (NYSE:ONTO), downgrading the stock from Overweight to Neutral and significantly reducing the price target to $135 ...

On Tuesday, Cantor Fitzgerald analyst Sarah James reaffirmed an Overweight rating on CVS Health (NYSE:CVS) with a steady price target of $71.00. The rating aligns with the company’s strong market ...

"We are proud to partner with Charleston County to support their commitment to maintaining safe and reliable roadways," said Nathan Kebede, National Lead for Pavement Services at Michael Baker ...